LymeDetect

Device DiaSorin Inc.
Total Payments
$392,747
Transactions
11
Doctors
0
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $155,123 2 0
2023 $195,229 5 0
2022 $42,395 4 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $392,747 11 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
LymeDetect 2022 Clinical Study DiaSorin Inc. $381,397 0
LymeDetect Clinical Study DiaSorin Inc. $9,500 0
ISA - LymeDetect (PROT.648.00024, Project 500544) Clinical study DiaSorin Inc. $1,000 0
ISA - LymeDetect (Project 500685) Clinical study DiaSorin Inc. $850.00 0

Top Doctors Receiving Payments for LymeDetect

Doctor Specialty Location Total Records
Unknown Saint Paul, MN $392,747 11

About LymeDetect

LymeDetect is a device associated with $392,747 in payments to 0 healthcare providers, recorded across 11 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Inc..

Payment data is available from 2022 to 2024. In 2024, $155,123 was paid across 2 transactions to 0 doctors.

The most common payment nature for LymeDetect is "Unspecified" ($392,747, 100.0% of total).

LymeDetect is associated with 4 research studies, including "LymeDetect 2022 Clinical Study" ($381,397).